GleamWall
中文EN

RDGL VIVOS INC

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1449349 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY392.2%
TTM net income YoY-27.1%
TTM EPS YoY-100.0%
Revenue 3-yr CAGR69.3%
Net income 3-yr CAGR—

Margins

Gross margin6.8%
Operating margin-2,414.0%
Net margin-3,032.9%
FCF margin—
EBITDA margin—

Returns

ROE-180.2%
ROA-167.1%
ROIC (approx.)-2,040.3%
Asset turnover0.06x

Leverage & solvency

Liabilities / assets9.7%
Debt / equity0.00x
Current ratio12.33x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.60x
Accruals ratio-66.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$28,900$36,400$36,068$24,752$1,879$15,000$26,748-$18,005
Cost of revenue$7,438$38,120$44,086$27,857$14,694$49,753$35,831$10,280
Gross profit$21,462-$1,720-$8,018-$3,105-$12,815-$34,753-$9,083-$5,285
R&D expense$31,802$49,182$37,923$57,166$67,820$107,965$119,281$100,969
SG&A expense$203,455$82,278$58,685$90,535$72,904$80,913$52,203$98,356
Operating income-$748,838-$654,529-$545,492-$1.10M-$531,023-$674,773-$863,532-$661,800
Pretax income-$731,594-$830,189-$1.18M-$1.08M-$507,294-$645,513-$834,696-$1.02M
Net income-$731,594-$830,189-$1.18M-$1.08M-$507,294-$645,513-$834,696-$1.02M
EBITDA-$740,639-$654,171-$535,531—————
EPS (basic)0.000.000.00—0.000.000.00—
EPS (diluted)0.000.000.00—0.000.000.00—
Weighted avg. shares (diluted)494.29M490.70M462.16M—454.30M453.51M448.23M—
Banking
Net interest income$17,244$20,340$12,275$17,205$23,729$29,260$28,836$19,612
Balance sheet
Cash & equivalents$1.81M$2.34M$2.53M$1.56M$2.20M$2.66M$3.27M$2.21M
Receivables$27,825$15,650$7,668$22,331$4,699$13,270$8,704$10,326
Inventory$55,997$56,427$56,863$57,257$62,734$62,961$21,198—
Current assets$1.91M$2.44M$2.60M$1.65M$2.30M$2.78M$3.30M$2.23M
PP&E, net$277,433$338,236$244,055$102,811————
Total assets$2.28M$2.88M$2.95M$1.87M$2.30M$2.78M$3.30M$2.23M
Current liabilities$155,179$49,973$171,737$117,892$112,693$96,458$115,378$86,209
Total liabilities$221,600$123,955$253,195$206,743$112,693$96,458$115,378$86,209
Shareholders' equity$2.06M$2.76M$2.70M$1.66M$2.18M$2.68M$3.19M$2.15M
Shares outstanding494.74M494.21M482.84M455.49M454.66M453.80M453.41M440.87M
Cash flow statement
Operating cash flow-$593,394-$739,580-$429,861-$539,554-$458,481-$604,510-$455,198-$470,912
Capital expenditure-$52,604$94,539$151,205—————
Free cash flow-$540,790-$834,119-$581,066—————
Investing cash flow$52,604-$94,539-$151,205—————
Financing cash flow$12,118$644,359$1.55M-$845$0$0$1.51M$1.47M
Depreciation & amortization$8,199$358$9,961—————

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.